![]() | ![]() | Log on / register BioMed Central home | Journals A-Z | Feedback | Support | My details |
home | issues | articles | reports | supplements | weblinks | conferences | search | information | subscribe | my details |
information |
|
About Breast Cancer Research |
|
|
Scope Scope Scope Scope |
Breast Cancer Research is an international, peer-reviewed online journal, publishing original research, reviews, commentaries and reports. Research articles of exceptional interest are published in all areas of biology and medicine relevant to breast cancer, including normal mammary gland biology, with special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition, the journal publishes clinical studies with a biological basis, including Phase I and Phase II trials. Lewis Chodosh is Breast Cancer Research's Editor-in-Chief, and is supported by a team of Deputy Editors - Hans-Olov Adami, Jenny Chang, Stephen RD Johnston and Sunil Lakhani. An international Editorial Board represent the full range of subjects covered in the journal. Breast Cancer Research - an online journal All articles in Breast Cancer Research are published in full online shortly after acceptance. Articles are published in PDF format suitable for printing, and a full text xml version that allows readers to:
Online publication allows authors to include additional files such as films or large datasets. In addition to the journal content, the website provides several other facilities for readers:
The open access journal Archivos de Medicina offers authors whose papers have been accepted for publication in Breast Cancer Research the option of publishing a Spanish translation of their article. Further details can be found here. Breast Cancer Research contains the following types of articles:
See below for a brief description of each. Editorials Commentaries
See the instructions for authors for more information. Reviews
See the instructions for authors for more information. Research To ensure the best possible service to authors and readers, we offer:
Research articles in Breast Cancer Research are open access, which means they are universally and freely accessible via the Internet and deposited in at least one widely and internationally recognized open access repository (such as PubMed Central). Authors retain copyright to their articles, and grant any third party the right to use, reproduce and disseminate the article, subject to the terms of the copyright license. To cover the costs incurred by open access publishing we levy an article processing charge for each accepted article. Please click here for more information. See the instructions for authors for more information. Viewpoints Meeting reports Letters
Publishing a supplement to Breast Cancer Research is an excellent way to disseminate conference material and scientific findings to a specialist audience. Breast Cancer Research accepts the following types of supplement: Proceedings, Review collections, and Meeting abstracts. All published supplements are fully searchable and freely accessible online and can also be produced in print. Articles published in Proceedings and Review collections are indexed by PubMed. Meeting abstracts are also included in PubMed, displayed by the title of the supplement. However, PubMed does not index individual abstracts. All articles will be subject to immediate screening by the Editorial Board. Articles that do not meet the scientific standards of the journal may be declined without further review. Appropriate articles will be sent to up to 3 referees who have agreed to assess the article rapidly. We will make every effort to reach decisions within 6 weeks of submission. If the referees have requested revisions, in general, only one revised version will be considered for further peer-review. Authors are asked to provide names and contact details for 2-4 referees. However, final selection of referees is the responsibility of the Editorial Board. All peer review is closed - authors are not given the names of the referees of their article. Editorial Board members and referees are asked to declare any competing interests they may have in reviewing a manuscript. On occasion, authors of rejected articles will be offered the opportunity to submit their research article to one of the other journals published by BioMed Central. Where relevant, the referee reports will be passed on to the second journal, which may expedite the peer review process. Referee reports are not passed on to any journal outside of BioMed Central. If an author is not satisfied with the decision made on their manuscript, they are welcome to contact the Editorial Office with their appeal. A second opinion on the manuscript will be sought where appropriate. Submission of an article to Breast Cancer Research implies that all contributors have read it and agree to its content. Material submitted to Breast Cancer Research must not have been simultaneously submitted for publication elsewhere. Once an article is accepted, it is published in Breast Cancer Research immediately as a provisional PDF file, with a final citation, and will be included in PubMed. The article will subsequently be copyedited and published in both a fully browseable web form and as a formatted PDF; the article will then be available through Breast Cancer Research, BioMed Central and PubMed Central. Research articles are open access, and commentaries, reviews and reports are available via subscription. All articles become free to access online six months after publication. Letters and editorials are free to access immediately on publication. With the exception of primary research articles, where the copyright rests with the authors as a default, copyright of material published in Breast Cancer Research belongs to the publisher, BioMed Central Ltd. Breast Cancer Research offers a high quality reprint service. For more information see our publisher's reprints and permissions policy or contact us. By being part of BioMed Central, Breast Cancer Research is a member of the Committee on Publication Ethics (COPE). For more information on COPE, see www.publicationethics.org.uk.
Discontinuation of Breast Cancer Research print issues |
|
|
| © 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media. |